Michael Zhang

Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study *

R. Sullivan, K. Flaherty, Dennie T. Frederick, 2022, The British journal of dermatology.

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

R. Sullivan, K. Flaherty, Dennie T. Frederick, 2021, Clinical Cancer Research.

5-Aminolevulinic Acid Imaging of Malignant Glioma.

Shruti Jain, Adrian J. Rodrigues, Guan Li, 2022, Surgical oncology clinics of North America.

Phase I Alexander study of AUTO3, the first CD19/22 dual targeting CAR T cell therapy, with pembrolizumab in patients with relapsed/refractory (r/r) DLBCL.

E. Tholouli, K. Ardeshna, P. Mcsweeney, 2020 .